Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Muller

Showing results (41-50 of 164) with videos related to

Pageof 17
Sort By:
Annals of Internal Medicine|December 1, 1980
Calcium channel blocking agents in the treatment of cardiovascular disorders. Part I: Basic and clinical electrophysiologic effectsE M Antman, P H Stone, J E Muller, et al.
Controlled Clinical Trials|April 1, 1995
Requirements for controlled clinical trials of preoperative cardiovascular risk reductionM C Cohen, C McKenna, S M Lewis, et al.
The New England Journal of Medicine|May 21, 1981
Sounding Boards. Let's not let the genie escape from the bottle--againJ E Muller, P H Stone, J E Markis, et al.
Cardiovascular Research|February 1, 1978
Effects of minoxidil on coronary collateral flow and acute myocardial injury following experimental coronary artery occlusionP Radvany, M A Davis, J E Muller, et al.
The American Journal of Medicine|January 1, 1983
Role of beta-adrenergic blockade in the therapy of patients with myocardial infarctionE Braunwald, J E Muller, R A Kloner, et al.
Annals of Internal Medicine|December 1, 1980
Calcium channel blocking agents in the treatment of cardiovascular disorders. Part II: Hemodynamic effects and clinical applicationsP H Stone, E M Antman, J E Muller, et al.
Journal of the American College of Cardiology|March 1, 1994
Triggers, acute risk factors and vulnerable plaques: the lexicon of a new frontierJ E Muller, G S Abela, R W Nesto, et al.
Journal of Cardiovascular Pharmacology|January 1, 1987
Circadian variation of cardiovascular disease and sympathetic activityJ E Muller, G H Tofler, S N Willich, et al.
Circulation|April 1, 1981
Prevention of nifedipine of abnormal coronary vasoconstriction in patients with coronary artery diseaseS Gunther, L Green, J E Muller, et al.
Pharmacotherapy|September 1, 1981
Nifedipine in the treatment of cardiovascular diseaseH S Mueller, E M Antman, J A Ferst, et al.
Pageof 17

Showing results (41-50 of 164) with videos related to

Sort By:
Pageof 17
Annals of Internal Medicine|December 1, 1980
Calcium channel blocking agents in the treatment of cardiovascular disorders. Part I: Basic and clinical electrophysiologic effectsE M Antman, P H Stone, J E Muller, et al.
Controlled Clinical Trials|April 1, 1995
Requirements for controlled clinical trials of preoperative cardiovascular risk reductionM C Cohen, C McKenna, S M Lewis, et al.
The New England Journal of Medicine|May 21, 1981
Sounding Boards. Let's not let the genie escape from the bottle--againJ E Muller, P H Stone, J E Markis, et al.
Cardiovascular Research|February 1, 1978
Effects of minoxidil on coronary collateral flow and acute myocardial injury following experimental coronary artery occlusionP Radvany, M A Davis, J E Muller, et al.
The American Journal of Medicine|January 1, 1983
Role of beta-adrenergic blockade in the therapy of patients with myocardial infarctionE Braunwald, J E Muller, R A Kloner, et al.
Annals of Internal Medicine|December 1, 1980
Calcium channel blocking agents in the treatment of cardiovascular disorders. Part II: Hemodynamic effects and clinical applicationsP H Stone, E M Antman, J E Muller, et al.
Journal of the American College of Cardiology|March 1, 1994
Triggers, acute risk factors and vulnerable plaques: the lexicon of a new frontierJ E Muller, G S Abela, R W Nesto, et al.
Journal of Cardiovascular Pharmacology|January 1, 1987
Circadian variation of cardiovascular disease and sympathetic activityJ E Muller, G H Tofler, S N Willich, et al.
Circulation|April 1, 1981
Prevention of nifedipine of abnormal coronary vasoconstriction in patients with coronary artery diseaseS Gunther, L Green, J E Muller, et al.
Pharmacotherapy|September 1, 1981
Nifedipine in the treatment of cardiovascular diseaseH S Mueller, E M Antman, J A Ferst, et al.
Pageof 17